Suppr超能文献

肝移植后的急性和慢性排斥反应:临床医生需要了解的内容。

Acute and Chronic Rejection After Liver Transplantation: What A Clinician Needs to Know.

作者信息

Choudhary Narendra S, Saigal Sanjiv, Bansal Rinkesh K, Saraf Neeraj, Gautam Dheeraj, Soin Arvinder S

机构信息

Institute of Liver Transplantation and Regenerative Medicine, Medanta The Medicity, Gurugram, India.

Department of Pathology, Medanta The Medicity, Gurugram, India.

出版信息

J Clin Exp Hepatol. 2017 Dec;7(4):358-366. doi: 10.1016/j.jceh.2017.10.003. Epub 2017 Nov 7.

Abstract

While antibody mediated hyper-acute vasculitic rejection is rare in liver transplant recipients, acute and chronic rejection have clinical significance. The liver allograft behaves differently to other solid organ transplants as acute rejection generally does not impair graft survival and chronic rejection (CR) is uncommon. The incidence of acute and chronic rejection has declined in current era due to improved immunosuppressive regimens. Acute rejection generally improves with steroid boluses and steroid resistant rejection is uncommon. CR may improve with escalation of immunosuppression or may result in irreversible loss of graft function leading to retransplantation or death. The current review discusses diagnosis and management of acute and chronic liver allograft rejection.

摘要

虽然抗体介导的超急性血管性排斥反应在肝移植受者中很少见,但急性和慢性排斥反应具有临床意义。肝移植受者的肝脏移植物与其他实体器官移植表现不同,因为急性排斥反应通常不会损害移植物存活,而慢性排斥反应并不常见。由于免疫抑制方案的改进,当前时代急性和慢性排斥反应的发生率有所下降。急性排斥反应通常通过大剂量类固醇治疗而改善,对类固醇耐药的排斥反应并不常见。慢性排斥反应可能随着免疫抑制的升级而改善,也可能导致移植物功能不可逆转的丧失,从而导致再次移植或死亡。本综述讨论了肝移植急性和慢性排斥反应的诊断和管理。

相似文献

1
Acute and Chronic Rejection After Liver Transplantation: What A Clinician Needs to Know.
J Clin Exp Hepatol. 2017 Dec;7(4):358-366. doi: 10.1016/j.jceh.2017.10.003. Epub 2017 Nov 7.
5
Durable Clinical and Immunologic Advantage of Living Donor Liver Transplantation in Children.
Transplantation. 2018 Jun;102(6):953-960. doi: 10.1097/TP.0000000000002110.
6
Sex mismatch as a risk factor for chronic rejection of liver allografts.
Lancet. 1995 Oct 28;346(8983):1117-21. doi: 10.1016/s0140-6736(95)91797-7.
8
Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies.
Cardiol Young. 2011 Dec;21 Suppl 2:124-32. doi: 10.1017/S1047951111001703.
9
Marked Differences in acute cellular rejection rates between living-donor and deceased-donor liver transplant recipients.
Transplantation. 2005 Oct 27;80(8):1072-80. doi: 10.1097/01.tp.0000176483.52769.5a.

引用本文的文献

1
Mixed Cellular and Antibody-Mediated Rejection-A Rare yet Morbid Occurrence.
ACG Case Rep J. 2024 Sep 27;11(10):e01518. doi: 10.14309/crj.0000000000001518. eCollection 2024 Oct.
2
Role of autophagy in rejection after solid organ transplantation: A systematic review of the literature.
World J Transplant. 2025 Sep 18;15(3):103163. doi: 10.5500/wjt.v15.i3.103163.
4
Severe acute allograft rejection 22 years after liver transplantation.
Can Liver J. 2024 Dec 19;7(4):500-504. doi: 10.3138/canlivj-2024-0004. eCollection 2024 Dec.
5
Reshaping transplantation with AI, emerging technologies and xenotransplantation.
Nat Med. 2025 Jul 14. doi: 10.1038/s41591-025-03801-9.
6
Long-Term Survival and Recurrence in HCC vs. Non-HCC Liver Transplant Recipients: A Two-Decade Longitudinal Analysis.
J Clin Exp Hepatol. 2025 May-Jun;15(3):102489. doi: 10.1016/j.jceh.2024.102489. Epub 2024 Dec 16.
7
The effects of interleukin-21 in the biology of transplant rejection.
Front Immunol. 2025 May 1;16:1571828. doi: 10.3389/fimmu.2025.1571828. eCollection 2025.
8
Regulatory B cells, the key regulator to induce immune tolerance in organ transplantation.
Front Immunol. 2025 Apr 8;16:1561171. doi: 10.3389/fimmu.2025.1561171. eCollection 2025.
9
Update on the Complications and Management of Liver Cirrhosis.
Med Sci (Basel). 2025 Feb 5;13(1):13. doi: 10.3390/medsci13010013.

本文引用的文献

2
[Strategies in clinical diagnosis and treatment of steroid-resistant acute rejection after orthotopic liver transplantation].
Zhonghua Gan Zang Bing Za Zhi. 2016 Apr;24(4):297-301. doi: 10.3760/cma.j.issn.1007-3418.2016.04.011.
3
Efficacy of rabbit anti-thymocyte globulin for steroid-resistant acute rejection after liver transplantation.
Medicine (Baltimore). 2016 Jun;95(23):e3711. doi: 10.1097/MD.0000000000003711.
4
2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection.
Am J Transplant. 2016 Oct;16(10):2816-2835. doi: 10.1111/ajt.13909. Epub 2016 Jul 14.
6
Late acute rejection in liver transplant: a systematic review.
Arq Bras Cir Dig. 2015 Jul-Sep;28(3):212-5. doi: 10.1590/S0102-67202015000300017.
8
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease.
Gastroenterology. 2015 Sep;149(3):649-59. doi: 10.1053/j.gastro.2015.05.010. Epub 2015 May 15.
9
Current status of immunosuppression in liver transplantation.
J Clin Exp Hepatol. 2013 Jun;3(2):150-8. doi: 10.1016/j.jceh.2013.04.005. Epub 2013 Jun 3.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验